Klickstein Lloyd 4
4 · Adicet Bio, Inc. · Filed Mar 18, 2021
Insider Transaction Report
Form 4
Adicet Bio, Inc.ACET
Klickstein Lloyd
Director
Transactions
- Award
Common Stock
2019-12-06−16,888→ 16,888 total - Tax Payment
Common Stock
2020-10-23−4,957→ 11,931 total
Footnotes (3)
- [F1]The Reporting Person was issued Restricted Stock Units ("RSU"). Each RSU represents a contingent right to receive one share of common stock. The RSUs shall vest in four (4) annual installments, with the first tranche vesting on December 6, 2020. The RSUs may be settled only by delivering shares of common stock, and thus, the grant is being reported in Table I as allowed per SEC guidance
- [F2]The amount of securities reported herein have been adjusted to reflect the 1-for-7 reverse stock split that was effected in September 2020 in connection with the merger of resTORbio, Inc. and Adicet Therapeutics, Inc., formerly known as Adicet Bio, Inc.
- [F3]The Reporting Person is disposing of 4,957 restricted stock units as a result of a revised tax rate for such restricted stock units